Advancing the World of Health from Utah.

• Author: Fredericks, Rob

BD (Becton, Dickinson and Company) is one of the world's largest medical technology companies and is a healthcare leader that is advancing the world of health by helping the people who help the patients. The company provides technology, services, solutions, and expertise to those on the frontlines of healthcare, as well as medical technology and interventions for patients. BD is focused on providing solutions to key challenges facing the global healthcare system including increasing access to healthcare, enhancing patient outcomes, improving safety, and reducing costs.

BD + BARD

In December 2017, BD completed the acquisition of C. R. Bard, Inc., which was a transformative moment for both companies and for the healthcare industry at large. Thanks to the merger, BD has strong category leadership in areas that are critical to the future of healthcare. The company leads in vascular access options, including PICCs (peripherally inserted central catheters), midlines, and drug delivery ports, as well as leadership and innovation in IV drug preparation, medication dispensing, intelligent and connected infusion systems, and comprehensive analytics. These advantages provide end to end medication management solutions across the care continuum. With healthcare-associated infections (HAIs) costing the U.S. healthcare system more than $35 billion per year, BD is well-positioned to provide direct solutions that address 75 percent of the most costly and frequent HAIs. BD leads in clinical therapies and medical technologies for costly diseases such as peripheral vascular disease, chronic kidney disease, and diabetes. Those three diseases alone have a cost burden of more than $400 billion annually. Antimicrobial resistance (AMR's) another emerging threat, is projected to grow to 10 million deaths by 2050, making it deadlier than cancer. BD is helping to lead fundamental change in the treatment of these conditions by developing medical technology to help prevent the spread of infections, provide accurate diagnosis to ensure proper treatment, and using surveillance and reporting to ensure that the appropriate therapy is administered. These are just a few examples of the significant challenges and opportunities that the combination of BD and Bard can now address.

BD IN UTAH

BD has a proud history in Utah. The company traces its roots to Deseret Pharmaceutical, which started in Murray, Utah in 1956, and which BD acquired in 1986. Bard has had a presence in the...